Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy

다국어 초록 (Multilingual Abstract)

Malignant progression is greatly affected by dynamic cross-talk between stromal and cancer cells. Exosomes are secreted nanovesicles that have key roles in cell–cell communication by transferring nucleic acids and proteins to target cells and tissues.
Recently, MicroRNAs (miRs) and their delivery in exosomes have been implicated in physiological and pathological processes. Tumor-delivered miRs, interacting with stromal cells in the tumor microenvironment, modulate tumor progression, angiogenesis, metastasis and immune escape. Altered cell metabolism is one of the hallmarks of cancer. A number of different types of tumor rely on mitochondrial metabolism by triggering adaptive mechanisms to optimize their oxidative phosphorylation in relation to their substrate supply and energy demands. Exogenous exosomes can induce metabolic reprogramming by restoring the respiration of cancer cells and supress tumor growth. The exosomal miRs involved in the modulation of cancer metabolism may be potentially utilized for better diagnostics and therapy.

참고문헌 (Reference)

1 Nouraee N, "miRNA therapeutics in cardiovascular diseases : promises and problems" 6 : 232-, 2015

2 Esau C, "miR-122regulation of lipid metabolism revealed by in vivo antisense targeting" 3 : 87-98, 2006

3 Takahashi Y, "Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection" 165 : 77-84, 2013

4 Kosaka N, "Versatile roles of extracellular vesicles in cancer" 126 : 1163-1172, 2016

5 Lima LG, "Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner" 283 : 168-175, 2009

6 Ye SB, "Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma" 5 : 5439-5452, 2014

7 Mantovani A, "Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions" 33 : 1478-1483, 2013

8 Amin DN, "Tumor endothelial cells express epidermal growth factor receptor(EGFR)but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors" 66 : 2173-2180, 2006

9 Deryugina EI, "Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature" 44-46 : 94-112, 2015

10 Hida K, "Tumor angiogenesis-characteristics of tumor endothelial cells" 21 : 206-212, 2016

11 Deryugina EI, "Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment" 16 : 771-788, 2014

12 Qin X, "The tumor cytosol miRNAs, fluid miRNAs, and exosome miRNAs in lung cancer" 4 : 357-, 2015

13 Peinado H, "The secreted factors responsible for pre-metastatic niche formation : old sayings and new thoughts" 21 : 139-146, 2011

14 Mezawa Y, "The roles of tumor-and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas" 365 : 675-689, 2016

15 Guo BB, "The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes" 290 : 3455-3467, 2015

16 Weber JA, "The microRNA spectrum in 12 body fluids" 56 : 1733-1741, 2010

17 Sessa R, "The miR-126 regulates angiopoietin-1 signaling and vessel maturation by targeting p85β" 1823 : 1925-1935, 2012

18 Druzhkova IN, "The metabolic interaction of cancer cells and fibroblasts -coupling between NAD(P)H and FAD, intracellular pH and hydrogen peroxide" 15 : 1257-1266, 2016

19 Csibi A, "The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4" 153 : 840-854, 2013

20 Ryu HS, "The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes" 6 : e17343-, 2011

21 Lamaze C, "The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells" 272 : 20332-20335, 1997

22 Hemler ME, "Tetraspanin functions and associated microdomains" 6 : 801-811, 2005

23 Doherty JR, "Targeting lactate metabolism for cancer therapeutics" 123 : 3685-3692, 2013

24 Wu J, "Targeting insulin-like growth factor axis in hepatocellular carcinoma" 4 : 30-, 2011

25 Fader CM, "TI-VAMP/VAMP7 and VAMP3/cellubrevin : two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways" 1793 : 1901-1916, 2009

26 Ohno S, "Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells" 21 : 185-191, 2013

27 Villarroya-Beltri C, "Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs" 4 : 2980-, 2013

28 Le A, "Studying Myc's role in metabolism regulation" 1012 : 213-219, 2013

29 Villarroya-Beltri C, "Sorting it out : regulation of exosome loading" 28 : 3-13, 2014

30 Knight ZA, "Small molecule inhibitors of the PI3-kinase family" 347 : 263-278, 2010

31 Hu Z, "Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer" 28 : 1721-1726, 2010

32 Guduric-Fuchs J, "Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types" 13 : 357-, 2012

33 Laura Ann Mulcahy, "Routes and mechanisms of extracellular vesicle uptake" Informa UK Limited 3 (3): 24641-, 2014

34 Huang TH, "Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer" 33 : 3636-3647, 2014

35 Robbins PD, "Regulation of immune responses by extracellular vesicles" 14 : 195-208, 2014

36 Phuyal S, "Regulation of exosome release by glycosphingolipids and flotillins" 281 : 2214-2227, 2014

37 Motohashi N, "Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis" 126 : 2678-2691, 2013

38 Chen H, "Reduced miR-126expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A" 5 : 11873-11885, 2014

39 Fiaschi T, "Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay" 72 : 5130-5140, 2012

40 Shen B, "Protein targeting to exosomes/microvesicles by plasma membrane anchors" 286 : 14383-14395, 2011

41 Hessvik NP, "Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells" 1819 : 1154-1163, 2012

42 Xie Y, "Power of PTEN/AKT : molecular switch between tumor suppressors and oncogenes" 12 : 375-378, 2016

43 Kidd S, "Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma" 7 : e30563-, 2012

44 Dearth RK, "Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate(IRS)-1 and IRS-2" 6 : 705-713, 2007

45 Kosaka N, "Neutral sphingomyelinase 2(nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis" 288 : 10849-10859, 2013

46 Grange C, "Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche" 71 : 5346-5356, 2011

47 Nouraee N, "MicroRNAs contribution in tumor microenvironment of esophageal cancer" 16 : 367-376, 2016

48 Gao P, "MicroRNAs and the Warburg effect : new players in an old arena" 12 : 285-291, 2012

49 Tomasetti M, "MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function" 21 : 2109-2125, 2014

50 Sun X, "MicroRNA-126 modulates the tumour microenvironment by targeting calmodulin-regulated spectrinassociated protein 1(Camsap1)" 44 : 1678-1684, 2014

51 Zhao X, "MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1" 11 : 1207-1212, 2016

52 Tomasetti M, "MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma" 7 : 36338-36352, 2016

53 Tsai WC, "MicroRNA-122plays a critical role in liver homeostasis and hepatocarcinogenesis" 122 : 2884-2897, 2012

54 Tomasetti M, "MicroRNA regulation of cancer metabolism : role in tumour suppression" 19 : 29-38, 2014

55 Camacho L, "MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes" 8 : e73790-, 2013

56 Rooj AK, "MicroRNA and extracellular vesicles in glioblastoma : small but powerful" 33 : 77-88, 2016

57 Cao M, "MiR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells" 140 : 1661-1670, 2014

58 Tao H, "MiR-126suppresses the glucose-stimulated proliferation via IRS-2 in INS-1 β cells" 11 : e0149954-, 2016

59 Li C, "Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer" 14 : 15-, 2016

60 Ward PS, "Metabolic reprogramming : a cancer hallmark even Warburg did not anticipate" 21 : 297-308, 2012

61 Phinney DG, "Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs" 6 : 8472-, 2015

62 Chalmin F, "Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells" 120 : 457-471, 2010

63 Peinado H, "Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET" 18 : 883-891, 2012

64 Hong CS, "MCT1 modulates cancer cell pyruvate export and growth of tumors that co-express MCT1 and MCT4" 14 : 1590-1601, 2016

65 Li X, "Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway" 9 : 42-, 2016

66 Rahman MA, "Lung cancer exosomes as drivers of epithelial mesenchymal transition" 7 : 54852-54866, 2016

67 Nielsen MF, "Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells" 22 : 2678-2700, 2016

68 Matsuda K, "Isolated tumor endothelial cells maintain specific character during longterm culture" 394 : 947-954, 2010

69 Li H, "Insulin receptor substrate-1and Golgi phosphoprotein 3 are downstream targets of miR‑126 in esophageal squamous cell carcinoma" 32 : 1225-1233, 2014

70 Eichelser C, "Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients" 5 : 9650-9663, 2014

71 Porter HA, "IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors" 338 : 239-248, 2013

72 Ghosh G, "Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis" 120 : 4141-4154, 2010

73 Cho Y, "Hypoxia enhances tumor-stroma crosstalk that drives the progression of hepatocellular carcinoma" 61 : 2568-2577, 2016

74 Ehnfors J, "Horizontal transfer of tumor DNA to endothelial cells in vivo" 16 : 749-757, 2009

75 Ratajczak MZ, "Horizontal transfer of RNA and proteins between cells by extracellular microvesicles : 14 years later" 5 : 7-, 2016

76 Valis K, "Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner" 71 : 946-954, 2011

77 Flaberg E, "High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts" 128 : 2793-2802, 2011

78 Hida K, "Heterogeneity of tumor endothelial cells and drug delivery" 99 : 140-147, 2016

79 Hanahan D, "Hallmarks of cancer : the next generation" 144 : 646-674, 2011

80 Garcia NA, "Glucose starvation in cardiomyocytes enhances exosome secretion and promotes angiogenesis in endothelial cells" 10 : e0138849-, 2015

81 Öhlund D, "Fibroblast heterogeneity in the cancer wound" 211 : 1503-1523, 2014

82 Desrochers LM, "Extracellular vesicles : satellites of information transfer in cancer and stem cell biology" 37 : 301-319, 2016

83 Wang H, "Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma" 2014 : 864894-, 2014

84 Li J, "Exosomes-derived MiR-302b suppresses lung cancer cell proliferation and migration via TGFβRII inhibition" 38 : 1715-1726, 2016

85 Li J, "Exosomes-derived MiR-302b suppresses lung cancer cell proliferation and migration via TGFβRII inhibition" 38 : 1715-1726, 2016

86 Katakowski M, "Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth" 335 : 201-204, 2013

87 Lou G, "Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma" 8 : 122-, 2015

88 Mathivanan S, "Exosomes : extracellular organelles important in intercellular communication" 73 : 1907-1920, 2010

89 Svensson KJ, "Exosome uptake depends on ERK1/2-heat shock protein 27 signalling and lipid raft-mediated endocytosis negatively regulated by caveolin-1" 288 : 17713-17724, 2013

90 Lespagnol A, "Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice" 15 : 1723-1733, 2008

91 Matsumura T, "Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer" 113 : 275-281, 2015

92 Rabinowits G, "Exosomal microRNA : a diagnostic marker for lung cancer" 10 : 42-46, 2009

93 Munagala R, "Exosomal miRNAs as biomarkers of recurrent lung cancer" 37 : 10703-10704, 2016

94 Ye SB, "Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma" 240 : 329-340, 2016

95 Wei Y, "Exosomal miR-221/222enhances tamoxifen resistance in recipient ER-positive breast cancer cells" 147 : 423-431, 2014

96 Squadrito ML, "Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells" 8 : 1432-1446, 2014

97 Morelli AE, "Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells" 104 : 3257-3266, 2004

98 Rodríguez M, "Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer" 53 : 713-724, 2014

99 Munoz JL, "Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity" 2 : e126-, 2013

100 Vicent S, "Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo" 72 : 5744-5756, 2012

101 Chang Q, "Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors : Therapeutic implications" 62 : 6035-6038, 2002

102 Shi J., "Considering exosomal miR-21 as a biomarker for cancer" 5 : pii E42-, 2016

103 Kosaka N, "Competitive interactions of cancer cells and normal cells via secretory microRNAs" 287 : 1397-1405, 2012

104 Tanaka Y, "Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma" 119 : 1159-1167, 2013

105 Fabris L, "Circulating free xeno-microRNAs-The new kids on the block" 10 : 503-508, 2016

106 Mishra P, "Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy" 89 : 31-39, 2011

107 Garcia NA, "Cardiomyocyte exosomes regulate glycolytic flux in endothelium by direct transfer of GLUT transporters and glycolytic enzymes" 109 : 397-408, 2016

108 Zhou W, "Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis" 25 : 501-515, 2014

109 Cirri P, "Cancer-associated-fibroblasts and tumour cells : a diabolic liaison driving cancer progression" 31 : 195-208, 2012

110 Shiga K, "Cancer-associated fibroblasts : their characteristics and their roles in tumor growth" 7 : 2443-2458, 2015

111 Melo SA, "Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis" 26 : 707-721, 2014

112 Christianson HC, "Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity" 110 : 17380-17385, 2013

113 Cirri P, "Cancer associated fibroblasts : the dark side of the coin" 1 : 482-497, 2011

114 Fong MY, "Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis" 17 : 183-194, 2015

115 Doherty JR, "Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis" 74 : 908-920, 2014

116 Kowal J, "Biogenesis and secretion of exosomes" 29 : 116-125, 2014

117 Kowal J, "Biogenesis and secretion of exosomes" 29 : 116-125, 2014

118 Dreyer F, "Biogenesis and functions of exosomes and extracellular vesicles" 1448 : 201-216, 2016

119 Mocharla P, "AngiomiR-126 expression and secretion from circulating CD34(+)and CD14(+)PBMCs : role for proangiogenic effects and alterations in type 2diabetics" 121 : 226-236, 2013

120 Colombo M, "Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles" 126 : 5553-5565, 2013

121 Silverman JM, "An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages" 123 : 842-852, 2010

122 Masamune A, "Alteration of the microRNA expression profile during the activation of pancreatic stellate cells" 49 : 323-331, 2014

123 Ghosh AK, "Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells" 113 : 5568-5574, 2009

124 Bauer DE, "ATP citrate lyase is an important component of cell growth and transformation" 24 : 6314-6322, 2005

125 Hida K, "A new perspective on tumor endothelial cells : unexpected chromosome and centrosome abnormalities" 65 : 2507-2510, 2005

126 Pertega-Gomes N, "A glycolytic phenotype is associated with prostate cancer progression and aggressiveness : a role for monocarboxylate transporters as metabolic targets for therapy" 236 : 517-530, 2015